Home/Compounds/Pharmaceutical Intermediate/4-methyl-6-(1-methyl-1H-benzimidazol-2-yl)-2-propyl-1H-benzimidazole monohydrate
C19H22N4O
322.4 g/mol
Pharmaceutical IntermediateWarning
4-Methyl-6-(1-methyl-1H-benzimidazol-2-yl)-2-propyl-1H-benzimidazole monohydrate
CAS1282554-35-1
Category
Pharmaceutical Intermediate
Compound Class
Heterocycle
Primary Use
Pharmaceutical Intermediate
This compound is a hydrated heterocyclic substance used as a pharmaceutical intermediate in the manufacturing of telmisartan. It consists of a benzimidazole-based core structure with multiple aromatic rings.
Pharmaceutical intermediate for telmisartan production
Content scope: Information here supports chemical identification and industrial supply, research, and manufacturing contexts. It is not a therapeutic claim, medical advice, or drug-use instructions.
Sourcing or supplying this compound?
List your inventory or post a purchase request
CAS 1282554-35-1
Related Compounds
StrongSame Parent
4-methyl-6-(1-methyl-1H-benzimidazol-2-yl)-2-propyl-1H-benzimidazole
CAS152628-02-9
pharmaceutical intermediate
ReferenceSame Category
Methyl 6-(4-methoxyphenyl)-2-naphthoate
CAS128272-36-6
pharmaceutical intermediate
ReferenceSame Category
(S)-2-((1R,3aS,7aR,E)-4-((E)-2-((3S,5R)-3,5-bis(tert-butyldimethylsilyloxy)-2-methylenecyclohexylidene)ethylidene)-7a-methyloctahydro-1H-inden-1-yl)propan-1-ol
CAS128387-35-9
pharmaceutical intermediate
ReferenceSame Category
3-(Difluoromethoxy)-2,4,5-trifluorobenzoic acid
CAS128426-86-8
pharmaceutical intermediate
ReferenceSame Category
4-Fluoro-3-methoxybenzaldehyde
CAS128495-46-5
pharmaceutical intermediate
Safety Reference
Warning
H373May cause damage to organs through prolonged or repeated exposure
H400Very toxic to aquatic life
H410Very toxic to aquatic life with long lasting effects
Identifiers
IUPAC Name
4-methyl-6-(1-methylbenzimidazol-2-yl)-2-propyl-1H-benzimidazole;hydrate
InChIKey
SNCXGDVWYWJWRT-UHFFFAOYSA-N
SMILES
CCCC1=NC2=C(N1)C=C(C=C2C)C3=NC4=CC=CC=C4N3C.O
Synonyms (6)
—